文献速递头颈部肿瘤放疗姑息放疗与转移瘤

口咽癌放疗幸存者睡眠相关症状与生存的关联:大型前瞻性纵向队列研究

Sleep-related symptoms are associated with survival in oropharyngeal cancer radiotherapy survivors: Temporal characterization of patient-reported outcomes in a large-scale prospective longitudinal cohort.
PubMed 文献 · Radiother Oncol · 2026-09-26

该研究基于372例接受根治性放疗(±化疗)的口咽癌患者纵向队列,采用MDASI-HN量表在放疗前、放疗开始、放疗结束及放疗后6个月评估疲劳、睡眠障碍和嗜睡症状。严重睡眠相关症状在放疗结束时达峰,纵向严重疲劳(HR 5.05)、睡眠障碍(HR 3.86)和嗜睡(HR 8.24)均与更差的总生存独立相关。

要点

  • 严重疲劳、睡眠障碍和嗜睡在放疗结束时达峰,6个月时回落至接近基线。
  • 纵向严重疲劳、睡眠障碍和嗜睡均与更差的总生存独立相关。
  • 放疗开始时严重症状亦与更差生存相关,提示早期症状评估有预后价值。

核心结论

  • 严重睡眠相关症状在放疗期间达峰,纵向及放疗开始时严重疲劳、睡眠障碍和嗜睡均与口咽癌放疗患者更差的总生存相关。

研究设计与样本

  • 回顾性分析纳入372例在三级中心接受根治性放疗(±化疗)的口咽癌患者纵向队列。
  • 采用MDASI-HN在放疗前基线、放疗开始、放疗结束及放疗后6个月评估疲劳、睡眠障碍和嗜睡症状。
  • 总生存采用Kaplan-Meier和多变量Cox模型评估。

主要发现

  • 严重疲劳、睡眠障碍和嗜睡在基线不常见,放疗结束时分别达26%、15%和18%,放疗后6个月回落至6%、4%和2%。
  • 纵向严重疲劳(HR 5.05)、睡眠障碍(HR 3.86)和嗜睡(HR 8.24)均与更差总生存独立相关。
  • 放疗开始时严重疲劳(HR 3.58)、睡眠障碍(HR 5.08)和嗜睡(HR 7.76)亦与更差总生存相关(均p < 0.05)。
  • 多变量调整后,除年龄外,严重平均每日症状评分和放疗开始时严重症状与总生存相关。

关键数值与推荐

  • 严重疲劳、睡眠障碍和嗜睡在放疗结束时分别为26%、15%和18%,放疗后6个月分别为6%、4%和2%。
  • 纵向严重疲劳HR 5.05、睡眠障碍HR 3.86、嗜睡HR 8.24与更差总生存相关。
  • 放疗开始时严重疲劳HR 3.58、睡眠障碍HR 5.08、嗜睡HR 7.76与更差总生存相关(均p < 0.05)。

临床怎么用

  • 放疗期间及放疗开始时评估严重疲劳、睡眠障碍和嗜睡可能有助于识别需要支持性评估的高风险患者。
  • 观察性关联不确立因果关系,症状评估可作为支持性照护的参考而非预后干预依据。

局限性

  • 为回顾性分析,观察性关联不能确立因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Sleep-related symptoms in head and neck cancer are poorly characterized and often under-recognized. We examined symptom trajectories, prevalence of moderate/severe symptoms, and associations between severe sleep-related patient-reported symptoms and overall survival (OS) in oropharyngeal cancer (OPC) patients receiving radiotherapy (RT). METHODS: This retrospective analysis included a longitudinal cohort of 372 patients with OPC treated with curative-intent RT (± chemotherapy) at a tertiary center. Symptoms were assessed at the earliest available pre-RT baseline, RT start, RT end, and 6 months post-RT using the MD Anderson Symptom Inventory-Head and Neck (MDASI-HN). The sleep-related symptom domains were fatigue, sleep disturbance, and drowsiness. OS was evaluated using Kaplan-Meier and multivariable Cox models. RESULTS: Severe fatigue, sleep disturbance, and drowsiness were infrequent at baseline but peaked at RT end (26%, 15%, and 18%, respectively) and returned to near-baseline levels by 6 months (6%, 4%, and 2%). Severe longitudinal fatigue (HR 5.05), sleep disturbance (HR 3.86), and drowsiness (HR 8.24) were independently associated with worse OS. Severe symptoms at RT start were also associated with worse OS (fatigue HR 3.58; sleep disturbance HR 5.08; drowsiness HR 7.76; all p < 0.05). Aside from age, severe average daily symptom scores and severe symptoms at RT start were associated with OS after multivariable adjustment. CONCLUSION: Severe sleep-related symptoms peaked during RT. Severe fatigue, sleep disturbance, and drowsiness, both longitudinally and at RT start, were associated with worse OS. These observational associations do not establish causality; symptom assessment may help identify patients who warrant supportive evaluation.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Carevic G, Floyd W, Gaur R, et al. Sleep-related symptoms are associated with survival in oropharyngeal cancer radiotherapy survivors: Temporal characterization of patient-reported outcomes in a large-scale prospective longitudinal cohort. Radiother Oncol. 2026. PMID: 42800678. doi:10.1016/j.radonc.2026.111778

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。